The event was attended by 500 students from Rayalaseema districts, Visakhapatnam, Guntur, Bapatla and the neighbouring states ...

Analysts at Jefferies said that Indian pharmaceutical businesses, who depend heavily on the United States for their income, ...

US President Trump announced a 27% tariff on India, affecting auto and IT sectors. Indian equity indices fell, but pharma ...

Donald Trumps new 26% tariff on Indian imports has raised concerns about India's economic growth and export viability. While the pharmaceutical sector is temporarily exempt, brokerages warn of ...

If United States President Donald Trump's proposed 10 per cent flat tariff and country-specific tariffs -- including a 26 per ...

The US administration has not made announcements yet on sector-specific tariffs, and hence it is unclear at the moment if ...

India pharmaceutical stocks soared today after US President Donald Trump imposed a 26% reciprocal tariff on India but excluded the pharma sector from the levies.

Shares of Indian pharma companies with significant US exposure surged by up to 14% after President Trump refrained from ...

Get all latest & breaking news on Stock Radar. Watch videos, top stories and articles on Stock Radar at moneycontrol.com.

The Trump administration’s blanket 26 per cent tariff on Indian imports has triggered sharp market reactions, with stocks ...

It’s a party for pharma stocks on Dalal Street. The Nifty Plarma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA ...

The exemption applies broadly to all pharmaceutical products, ensuring that the drugmakers avoid immediate cost pressures ...